Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
East Mediterr Health J ; 10(4-5): 627-32, 2004.
Article in English | MEDLINE | ID: mdl-16335655

ABSTRACT

Antiphospholipid antibodies may play and important role in the pathogenesis of retinal vascular occlusions; investigated the prevalence among 33 patients with retinal vein and artery occlusions and 80 controls. Prevalence was 33% and 5% respectively. Ophthalmic examination and fluorescein angiography showed that occlusions were due to ischaemic events. The 11 patients were diagnosed with antiphospholipid syndrome: 9 patients were treated successfully with laser photocoagulation and anticoagulant and anti-aggregant therapy. Two patients with antiphospholipid antibodies associated with resistance to activated protein C had unfavourable outcomes. Our results suggest a correlation between antiphospholipid syndrome and retinal vein occlusions; we recommend a systematic search for antiphospholipid antibodies in occlusions of unexplained origin and laser photocoagulation treatment and long-term oral anticoagulant and anti-aggregant therapy.


Subject(s)
Antiphospholipid Syndrome/complications , Retinal Vein Occlusion/etiology , Administration, Oral , Adult , Aged , Antibodies, Antiphospholipid/blood , Anticoagulants/therapeutic use , Antiphospholipid Syndrome/diagnosis , Antiphospholipid Syndrome/epidemiology , Antiphospholipid Syndrome/therapy , Case-Control Studies , Chi-Square Distribution , Female , Fluorescein Angiography , Humans , Laser Coagulation , Male , Mass Screening , Middle Aged , Ophthalmoscopy , Prevalence , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/epidemiology , Retinal Vein Occlusion/therapy , Surveys and Questionnaires , Treatment Outcome , Tunisia/epidemiology
2.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-119459

ABSTRACT

Antiphospholipid antibodies may play and important role in the pathogenesis of retinal vascular occlusions; investigated the prevalence among 33 patients with retinal vein and artery occlusions and 80 controls. Prevalence was 33% and 5% respectively. Ophthalmic examination and fluorescein angiography showed that occlusions were due to ischaemic events. The 11 patients were diagnosed with antiphospholipid syndrome: 9 patients were treated successfully with laser photocoagulation and anticoagulant and anti-aggregant therapy. Two patients with antiphospholipid antibodies associated with resistance to activated protein C had unfavourable outcomes. Our results suggest a correlation between antiphospholipid syndrome and retinal vein occlusions; we recommend a systematic search for antiphospholipid antibodies in occlusions of unexplained origin and laser photocoagulation treatment and long-term oral anticoagulant and anti-aggregant therapy


Subject(s)
Administration, Oral , Antibodies, Antiphospholipid , Anticoagulants , Case-Control Studies , Chi-Square Distribution , Fluorescein Angiography , Laser Coagulation , Retinal Vein Occlusion , Antiphospholipid Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...